Analyzing Stryker (NYSE:SYK) and NAYA Biosciences (NASDAQ:NAYA)

Stryker (NYSE:SYK) and NAYA Biosciences (NASDAQ:NAYA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.

Profitability

This table compares Stryker and NAYA Biosciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Stryker	13.25%	23.58%	11.37%
NAYA Biosciences	-119.91%	N/A	-41.72%

Risk and Volatility

Stryker has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, NAYA Biosciences has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500.

Insider and Institutional Ownership

77.1% of Stryker shares are owned by institutional investors. Comparatively, 12.0% of NAYA Biosciences shares are owned by institutional investors. 5.9% of Stryker shares are owned by company insiders. Comparatively, 1.8% of NAYA Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations for Stryker and NAYA Biosciences, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0	4	15	0	2.79
NAYA Biosciences	0	0	1	0	3.00

Stryker currently has a consensus target price of $427.30, suggesting a potential upside of 13.34%. NAYA Biosciences has a consensus target price of $24.00, suggesting a potential upside of 1,732.06%. Given NAYA Biosciences’ stronger consensus rating and higher possible upside, analysts plainly believe NAYA Biosciences is more favorable than Stryker.

Valuation & Earnings

This table compares Stryker and NAYA Biosciences”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stryker	$23.22 billion	6.20	$2.99 billion	$7.40	50.95
NAYA Biosciences	$6.23 million	0.14	-$8.03 million	N/A	N/A

Stryker has higher revenue and earnings than NAYA Biosciences.

Summary

Stryker beats NAYA Biosciences on 9 of the 12 factors compared between the two stocks.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

About NAYA Biosciences

NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.